The U.S. Food and Drug Administration expanded Johnson & Johnson’s Xarelto drug to also include treating and reducing the risk of deep-vein thrombosis and pulmonary embolism. Xarelto is currently used to reduce the risk of blood clots and strokes.
The expansion of the drug makes Xarelto the first oral, anti-clotting drug to reduce and treat blood clots since the drug warfarin was approved almost six decades ago. Both Johnson & Johnson and Bayer market the medication, according to the Washington Post.
Deep-vein thrombosis is a blood clot that forms in one of the body’s deep, large veins–usually in the legs. These blood clots can detach and travel throughout the body, making it potentially deadly if it enters the heart or lungs. It is called a pulmonary embolism when the clot is lodged near the lungs.
If you or someone you love has suffered from deep-vein thrombosis or a pulmonary embolism caused by the birth control pills Yaz or Yasmin, contact the birth control lawsuit attorneys of Williams Kherkher at 800-761-3187.